High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes
- PMID: 17245729
- DOI: 10.1002/jmv.20800
High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: significance of newly detected hr-HPV genotypes
Abstract
Large loop excision of the cervical transformation zone (LLETZ) is a well-established treatment for high-grade cervical intraepithelial neoplasia. It has even been postulated that LLETZ is responsible for the elimination of the infectious agent, human papillomavirus (HPV), causing the lesion. Most studies on HPV detection after LLETZ have focused on the persistence of high-risk (hr-) HPV to identify women at risk for residual or recurrent disease. Therefore, the appearance and significance of hr-HPV types newly detected after surgical treatment has not been studied extensively so far. The presence of hr-HPV in 85 high-grade squamous cervical LLETZ biopsies and in the first follow-up smear was determined. In 80 (94%) of the LLETZ biopsies hr-HPV was detected in contrast to 30 (35%) hr-HPV positive follow-up scrapes. Twenty of the 80 hr-HPV positive women (25%) had the same hr-HPV genotypes in their follow-up cervical smears as was found in the corresponding biopsies. In the follow-up smear of 13 women a new hr-HPV genotype was detected and HPV 18 was newly detected in 8 of them. The remarkably high presence of newly detected HPV 18 genotypes may argue for a release or re-activation of this virus from proximal layers of the cervical canal incised during surgery.
Similar articles
-
Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.J Med Virol. 2008 Jun;80(6):953-9. doi: 10.1002/jmv.21166. J Med Virol. 2008. PMID: 18428143
-
Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.J Clin Virol. 2009 Oct;46(2):176-9. doi: 10.1016/j.jcv.2009.07.017. Epub 2009 Aug 15. J Clin Virol. 2009. PMID: 19683958
-
Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15. doi: 10.1158/1055-9965.EPI-06-0846. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17416761 Clinical Trial.
-
HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy.Scand J Infect Dis. 2005;37(6-7):476-81. doi: 10.1080/00365540510036633. Scand J Infect Dis. 2005. PMID: 16012008
-
Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system.J Virol Methods. 2008 Feb;147(2):290-6. doi: 10.1016/j.jviromet.2007.09.018. Epub 2007 Nov 8. J Virol Methods. 2008. PMID: 17996311
Cited by
-
Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.Cochrane Database Syst Rev. 2015 Jan 6;1(1):CD010757. doi: 10.1002/14651858.CD010757.pub2. Cochrane Database Syst Rev. 2015. PMID: 25562623 Free PMC article.
-
The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.Gynecol Oncol. 2014 Mar;132(3):767-79. doi: 10.1016/j.ygyno.2013.12.040. Epub 2014 Jan 7. Gynecol Oncol. 2014. PMID: 24412508 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical